Visugromab, CAS 2556646-63-8

Product Description: Visugromab is aGDF-15 neutralizing IgG4 mAb. Visugromab exhibits potent effecicacy in PD-1/PD-L1 relapsed/refractory metastatic solid tumors[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Necchi A, et al. Neutralizing GDF-15 in muscle-invasive bladder cancer (MIBC): A neoadjuvant immunotherapy trial of visugromab (CTL-002) in combination with the anti-PD1 antibody nivolumab (NEO-GDFATHER)[J]. 2023.

CAS Number: 2556646-63-8

Molecular Weight: N/A

Compound Purity: 98.40

Research Area: Cancer

Solubility: 10 mM in DMSO/H2O

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99100-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99100-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK